|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ren SC, Chen R and Sun YH: Prostate cancer
research in China. Asian J Androl. 15:350–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sooriakumaran P, Nyberg T, Akre O,
Haendler L, Heus I, Olsson M, Carlsson S, Roobol MJ, Steineck G and
Wiklund P: Comparative effectiveness of radical prostatectomy and
radiotherapy in prostate cancer: Observational study of mortality
outcomes. BMJ. 348:g15022014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kahn B, Collazo J and Kyprianou N:
Androgen receptor as a driver of therapeutic resistance in advanced
prostate cancer. Int J Biol Sci. 10:588–595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shi X, Gipp J, Dries M and Bushman W:
Prostate progenitor cells proliferate in response to castration.
Stem Cell Res. 13:154–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ianni M, Porcellini E, Carbone I,
Potenzoni M, Pieri AM, Pastizzaro CD, Benecchi L and Licastro F:
Genetic factors regulating inflammation and DNA methylation
associated with prostate cancer. Prostate Cancer Prostatic Dis.
16:56–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu JB, Dai CM, Su XY, Cao L, Qin R and
Kong QB: Gene microarray assessment of multiple genes and signal
pathways involved in androgen-dependent prostate cancer becoming
androgen independent. Asian Pac J Cancer Prev. 15:9791–9795. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barclay AN and Brown MH: The SIRP family
of receptors and immune regulation. Nat Rev Immunol. 6:457–464.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hara K, Senga T, Biswas MH, Hasegawa H,
Ito S, Hyodo T, Hirooka Y, Niwa Y, Goto H and Hamaguchi M: Recovery
of anoikis in Src-transformed cells and human breast carcinoma
cells by restoration of the SIRP α1/SHP-2 signaling system. Cancer
Res. 71:1229–1234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan HX, Wang HY, Zhang R, Chen L, Li BA,
Liu SQ, Cao HF, Qiu XH, Shan YF, Yan ZH, et al: Negative regulation
of hepatocellular carcinoma cell growth by signal regulatory
protein alpha1. Hepatology. 40:618–628. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong XN, Yan HX, Chen L, Dong LW, Yang W,
Liu Q, Yu LX, Huang DD, Liu SQ, Liu H, et al: LPS-induced
down-regulation of signal regulatory protein {alpha} contributes to
innate immune activation in macrophages. J Exp Med. 204:2719–2731.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hinz M, Krappmann D, Eichten A, Heder A,
Scheidereit C and Strauss M: NF-kappaB function in growth control:
Regulation of cyclin D1 expression and G0/G1-to-S-phase transition.
Mol Cell Biol. 19:2690–2698. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Palchetti S, Starace D, de Cesaris P,
Filippini A, Ziparo E and Riccioli A: Transfected poly((I:C))
activates different dsRNA receptors, leading to apoptosis or
immunoadjuvant response in androgen-independent prostate cancer
cells. J Biol Chem. 290:5470–5483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Paone A, Starace D, Galli R, Padula F, de
Cesaris P, Filippini A, Ziparo E and Riccioli A: Toll-like receptor
3 triggers apoptosis of human prostate cancer cells through a
PKC-alpha-dependent mechanism. Carcinogenesis. 29:1334–1342. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun WH, Zhu F, Chen GS, Su H, Luo C, Zhao
QS, Zhang Y, Shao Y, Sun J, Zhou SM, et al: Blockade of
cholecystokinin-2 receptor and cyclooxygenase-2 synergistically
induces cell apoptosis, and inhibits the proliferation of human
gastric cancer cells in vitro. Cancer Lett. 263:302–311. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han JA, Kim JI, Ongusaha PP, Hwang DH,
Ballou LR, Mahale A, Aaronson SA and Lee SW: P53-mediated induction
of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis.
EMBO J. 21:5635–5644. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Casado M, Mollá B, Roy R,
Fernández-Martinez A, Cucarella C, Mayoral R, Boscá L and
Martin-Sanz P: Protection against Fas-induced liver apoptosis in
transgenic mice expressing cyclooxygenase 2 in hepatocytes.
Hepatology. 45:631–638. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nzeako UC, Guicciardi ME, Yoon JH, Bronk
SF and Gores GJ: COX-2 inhibits Fas-mediated apoptosis in
cholangiocarcinoma cells. Hepatology. 35:552–559. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Izhak L, Wildbaum G, Weinberg U, Shaked Y,
Alami J, Dumont D, Friedman B, Stein A and Karin N: Predominant
expression of CCL2 at the tumor site of prostate cancer patients
directs a selective loss of immunological tolerance to CCL2 that
could be amplified in a beneficial manner. J Immunol.
184:1092–1101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu Y, Cai Z, Galson DL, Xiao G, Liu Y,
George DE, Melhem MF, Yao Z and Zhang J: Monocyte chemotactic
protein-1 (MCP-1) acts as a paracrine and autocrine factor for
prostate cancer growth and invasion. Prostate. 66:1311–1318. 2006.
View Article : Google Scholar : PubMed/NCBI
|
